NCT04813185 Preventing Retaliatory Gun Violence in Violently Injured Adults
| NCT ID | NCT04813185 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Virginia Commonwealth University |
| Condition | Violence |
| Study Type | INTERVENTIONAL |
| Enrollment | 616 participants |
| Start Date | 2021-07-27 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 616 participants in total. It began in 2021-07-27 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study is to find out if a hospital-based violence intervention (Bridging the Gap) is effective for reducing violence. The researchers think that adults who receive Bridging the Gap will see greater improvements than those who do not receive the intervention. This study will allow them to learn more about the intervention's effectiveness. The study will also help them understand if the violence intervention affects other behaviors, such as firearm use, drug use, aggression, risky behaviors, and rates of violent re-injury.
Eligibility Criteria
Inclusion Criteria: * They receive treatment in the hospital for a violence-related injury (e.g., gunshot wound) * They are 18 years or older * They are English speaking * They are eligible for BTG services (which includes living within the BTG catchment area for the hospital; Richmond City and neighboring counties) Exclusion Criteria: * Non-English speaking * Age \<18 * Prisoners
Contact & Investigator
Nicholas Thomson
PRINCIPAL INVESTIGATOR
Virginia Commonwealth University
Frequently Asked Questions
Who can join the NCT04813185 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Violence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04813185 currently recruiting?
Yes, NCT04813185 is actively recruiting participants. Contact the research team at Nicholas.Thomson@vcuhealth.org for enrollment information.
Where is the NCT04813185 trial being conducted?
This trial is being conducted at Richmond, United States.
Who is sponsoring the NCT04813185 clinical trial?
NCT04813185 is sponsored by Virginia Commonwealth University. The principal investigator is Nicholas Thomson at Virginia Commonwealth University. The trial plans to enroll 616 participants.